Home >
Medicine Info >
LCD-125 Tablet
Loading interface...

LCD-125 Tablet

Manufactured byIntas Pharmaceuticals Ltd.
ContainsLevodopa (100 mg) + Carbidopa (25 mg)
Description
LCD-125 Tablet is a combination of Levodopa and Carbidopa. It is used to treat the symptoms of Parkinson's disease (a brain disorder that affects movement with symptoms such as tremors, shakiness, stiffness, difficulty in walking, impaired balance and coordination, etc.). It works by enhancing the action of a chemical substance called dopamine in the brain and relieving the symptoms associated with Parkinson's disease. LCD-125 Tablet shows side effects like nausea, vomiting, fatigue, constipation, dry mouth, loss of appetite, unusual dreams, trouble sleeping, etc. Consult your doctor if these side effects persist or become severe. Avoid driving vehicles or operating machines after taking this medicine, as it can make you feel dizzy. LCD-125 Tablet may be taken with or without food as directed by your doctor. The dose and duration of treatment will be decided by your doctor based on the severity of your condition. Take it at the same time every day to maintain a constant level of this medicine in your body. Do not stop taking it without consulting your doctor, as your symptoms could become worse. LCD-125 Tablet is not recommended for use if you are allergic to it. Inform your doctor if you have depression, mental conditions, liver or kidney problems, or any other health conditions before taking this medicine. Inform your doctor about all your current medicines to avoid any undesired effects. LCD-125 Tablet is not recommended for use in children below 18 years of age as the safety and efficacy data are not clinically established. Consult your doctor if you are pregnant, planning a pregnancy, or are breastfeeding.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for LCD-125 Tablet

  • Dizziness
  • Headache
  • Depression
  • Hallucinations
  • Dry mouth
  • Nausea and vomiting
  • Uncontrolled body movements
  • Confusion
  • Stomach pain
  • Abnormal dreams
  • Trouble sleeping
  • Loss of appetite
  • Fatigue

Uses of LCD-125 Tablet

What is it prescribed for?

  • Parkinson's Disease
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of LCD-125 Tablet can be observed within 20 to 50 minutes.
  • How long do the effects of this medicine last?
    The effect of LCD-125 Tablet lasts for approximately 2 to 3 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Avoid consuming alcohol during treatment with LCD-125 Tablet as it may increase the risk of side effects like depression and impairment of judgment, thinking, and psychomotor skills.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for LCD-125 Tablet.
  • Can this medicine be taken during pregnancy?
    LCD-125 Tablet is generally not recommended for use during pregnancy as animal studies indicate that it may harm the developing foetus. Hence, consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    LCD-125 Tablet is not recommended for use while breastfeeding as it is not known if this medicine passes into breastmilk. Consult your doctor if you are breastfeeding.

Allergy

Avoid taking LCD-125 Tablet if you are allergic to it. Seek medical attention if you experience symptoms such as skin rash, hives (itchy, painful eruptions that sting), swelling (especially of the face, lips, tongue, etc.), breathing difficulty, etc.

Narrow angle glaucoma

Narrow-angle glaucoma is a condition in which pressure inside your eyes increases. It occurs due to fluid build-up caused by blocked drainage canals (the structure inside the eye that allows fluid to drain normally from the eye). LCD-125 Tablet is not recommended for use if you have narrow-angle glaucoma as it may increase the risk of mydriasis (a condition in which the pupil of the eye gets widened) due to increased eye pressure.

Nonselective monoamine oxidase inhibitors (MAOIs)

Nonselective monoamine oxidase inhibitors (MAOIs) are a class of medicine used in the treatment of depression. LCD-125 Tablet is not recommended for use if you are taking MAOIs or have taken it in the past 14 days. Inform your doctor if you are taking any medicines, including herbs and supplements, before beginning treatment with LCD-125 Tablet.

Malignant Melanoma

Malignant melanoma is a type of skin cancer. LCD-125 Tablet may activate a malignant melanoma. Hence, it is not recommended for use if you have suspicious, undiagnosed skin lesions (a part of the skin that has an abnormal growth or appearance) or a history of malignant melanoma.
Warnings for special population

Pregnancy

LCD-125 Tablet is generally not recommended for use during pregnancy as animal studies indicate that it may harm the developing foetus. Hence, consult your doctor if you are pregnant.

Breast-feeding

LCD-125 Tablet is not recommended for use while breastfeeding as it is not known if this medicine passes into breastmilk. Consult your doctor if you are breastfeeding.
General warnings

Falling asleep during daily activities

LCD-125 Tablet should be used with caution due to the increased risk of drowsiness. It may also cause you to fall asleep during daily activities, rarely without awareness or warning signs. Hence, avoid performing activities that require high mental alertness like driving vehicles or operating machines while taking this medicine.

Compulsive behaviours

LCD-125 Tablet should be used with caution due to the increased risk of impulsive or compulsive behaviour like the intense urge to gamble, binge eating, or spend money. Report such unusual symptoms to your doctor on priority.

Liver disorders

LCD-125 Tablet should be used with caution if you have liver problems as it may further worsen your condition. Your doctor may suggest tests to monitor your liver function while you are taking this medicine.

Kidney disorders

LCD-125 Tablet should be used with caution if you have kidney problems as it may further worsen your condition. Your doctor may suggest tests to monitor your kidney function while you are taking this medicine.

Use in children

LCD-125 Tablet is not recommended for use in children below 18 years of age as the safety and efficacy data are not clinically established.

Low blood pressure levels

LCD-125 Tablet should be used with caution if you have hypotension (low blood pressure) or taking blood pressure-lowering medicines, as it may result in a significant drop in blood pressure when standing up.

Bronchospasm

LCD-125 Tablet may cause bronchospasm (narrowing of the airways). Hence, it is not recommended for use if you have respiratory conditions that cause narrowing of the airways and breathing difficulties, such as asthma and COPD (Chronic Obstructive Pulmonary Disease).

Gastrointestinal bleeding

LCD-125 Tablet may cause bleeding in the stomach and intestine. Hence, it should be used with caution if you have a history of stomach and intestinal ulcers or bleeding.

Missed Dose

Take the missed dose of LCD-125 Tablet as soon as you remember. If it is time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Never take more than the prescribed dose. Seek emergency medical treatment in case of an overdose of LCD-125 Tablet.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Avoid consuming alcohol during treatment with LCD-125 Tablet as it may increase the risk of side effects like depression and impairment of judgment, thinking, and psychomotor skills.
Interaction with Medicine

Nitrofurantoin

Amiodarone

Captopril

5-Hydroxytryptophan

Alprazolam

Atorvastatin

Furosemide

Droxidopa

Disease interactions

Psychosis

Psychosis is a mental condition that causes abnormal thinking and perceptions. The symptoms include confusion and hallucination. LCD-125 Tablet should be used with extreme caution if you have a history of psychosis as it may aggravate such conditions. Hallucinations and psychotic-like behaviour have been reported with the use of this medicine.

Depression

LCD-125 Tablet may cause depression and suicidal tendencies. Hence this medicine should be used with extreme caution if you have depression as it may further worsen your condition. Consult your doctor immediately if you experience changes in mood and behaviour or develop thoughts of self-harm while taking this medicine.

Neuroleptic Malignant Syndrome

Neuroleptic malignant syndrome is a rare life-threatening condition characterised by fever, an abnormally high body temperature, muscle rigidity, altered mental status, irregular pulse or blood pressure, etc. LCD-125 Tablet is not recommended for use if you have neuroleptic malignant syndrome as it may further worsen your condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
LCD-125 Tablet is used in treating symptoms of Parkinson's disease. Take this medicine with or without food, as advised by your doctor. Do not take in larger or smaller amounts than prescribed. Consult your doctor if you experience any undesirable effects that persist or worsen. Do not stop the use of LCD-125 Tablet without consulting your doctor as it may worsen your condition. LCD-125 Tablet can cause drowsiness and rarely sudden sleep episodes without warnings. Hence, avoid performing activities that require mental alertness such as driving vehicles or operating machines while you are taking this medicine. LCD-125 Tablet may increase the risk of depression and suicidal tendencies. Hence, consult your doctor immediately if you experience changes in mood and behaviour or develop suicidal thoughts.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Causes sleepiness

How it works
LCD-125 Tablet is a combination of Levodopa and Carbidopa. Levodopa gets converted into dopamine (a chemical messenger) in the brain and relieves the symptoms of Parkinson's disease. Carbidopa prevents the breakdown of Levodopa in the bloodstream, thus increasing the amount of Levodopa available for transport to the brain.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Dopaminergic Antiparkinsonism agents

Schedule

Schedule H

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 17 December 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/017555s069lbl.pdf>

Drugs, H., 2021. Levodopa and Carbidopa: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 17 December 2021].

https://medlineplus.gov/druginfo/meds/a601068.html>

Dailymed.nlm.nih.gov. 2021. DailyMed - CARBIDOPA AND LEVODOPA tablet. [online] Available at: < [Accessed 17 December 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a355d5f2-407d-40fa-a374-b3632261ea4a>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 17 Feb 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.